PriceTargets.com logo

Xponential Fitness - XPOF Stock Price Target and Predictions

  • Consensus Rating: Moderate Buy
  • Consensus Price Target: $17.28
  • Forecasted Upside: 31.09%
  • Number of Analysts: 10
  • Breakdown:
  • 0 Sell Ratings
  • 4 Hold Ratings
  • 4 Buy Ratings
  • 2 Strong Buy Ratings
$13.18 As of 10/22/2024 01:00 AM ET
▲ +0.37 (2.89%)

This chart shows the closing price for XPOF by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Xponential Fitness Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for XPOF and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for XPOF

Analyst Price Target is $17.28
▲ +31.09% Upside Potential
This price target is based on 10 analysts offering 12 month price targets for Xponential Fitness in the last 3 months. The average price target is $17.28, with a high forecast of $21.00 and a low forecast of $12.00. The average price target represents a 31.09% upside from the last price of $13.18.

This chart shows the closing price for XPOF for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Moderate Buy

The current consensus among 10 investment analysts is to moderate buy stock in Xponential Fitness. This rating has held steady since September 2023, when it changed from a Buy consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 1 strong buy ratings
  • 6 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
5/2/2023
  • 1 strong buy ratings
  • 6 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
7/31/2023
  • 1 strong buy ratings
  • 6 buy ratings
  • 2 hold ratings
  • 0 sell ratings
Ratings as of
10/29/2023
  • 1 strong buy ratings
  • 5 buy ratings
  • 3 hold ratings
  • 0 sell ratings
Ratings as of
1/27/2024
  • 1 strong buy ratings
  • 4 buy ratings
  • 3 hold ratings
  • 0 sell ratings
Ratings as of
4/26/2024
  • 2 strong buy ratings
  • 6 buy ratings
  • 3 hold ratings
  • 0 sell ratings
Ratings as of
7/25/2024
  • 2 strong buy ratings
  • 5 buy ratings
  • 4 hold ratings
  • 0 sell ratings
Ratings as of
9/23/2024
  • 2 strong buy ratings
  • 4 buy ratings
  • 4 hold ratings
  • 0 sell ratings
Ratings as of
10/23/2024

Latest Recommendations

  • 2 strong buy ratings
  • 4 buy ratings
  • 4 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
8/5/2024B. RileyBoost TargetNeutral ➝ Neutral$9.00 ➝ $12.00
8/2/2024Raymond JamesLower TargetStrong-Buy ➝ Strong-Buy$30.00 ➝ $20.00
8/2/2024Roth MkmLower TargetBuy ➝ Buy$22.00 ➝ $19.00
8/2/2024Robert W. BairdLower TargetNeutral ➝ Neutral$16.00 ➝ $15.00
8/2/2024Piper SandlerReiterated RatingNeutral ➝ Neutral$14.00 ➝ $13.00
7/11/2024Piper SandlerBoost TargetNeutral ➝ Neutral$9.00 ➝ $14.00
6/18/2024GuggenheimBoost TargetBuy ➝ Buy$18.00 ➝ $20.00
6/17/2024Roth CapitalUpgradeStrong-Buy
6/17/2024Roth MkmInitiated CoverageBuy$22.00
5/13/2024Piper SandlerLower TargetNeutral ➝ Neutral$12.00 ➝ $9.00
5/3/2024B. RileyBoost TargetBuy ➝ Buy$28.00 ➝ $31.00
4/12/2024Stifel NicolausReiterated RatingBuy ➝ Buy$20.00
3/13/2024Bank of AmericaBoost TargetNeutral ➝ Neutral$13.00 ➝ $15.50
3/5/2024Stifel NicolausBoost TargetBuy ➝ Buy$18.00 ➝ $20.00
3/4/2024CitigroupLower TargetBuy ➝ Buy$23.00 ➝ $21.00
3/1/2024Robert W. BairdLower TargetNeutral ➝ Neutral$16.00 ➝ $14.00
1/3/2024Piper SandlerReiterated RatingOverweight ➝ Neutral$21.00 ➝ $13.00
12/13/2023Stifel NicolausUpgradeHold ➝ Buy$18.00
11/15/2023GuggenheimLower TargetBuy ➝ Buy$30.00 ➝ $25.00
11/8/2023Raymond JamesLower TargetStrong-Buy ➝ Strong-Buy$40.00 ➝ $31.00
11/1/2023Bank of AmericaDowngradeBuy ➝ Neutral$35.00 ➝ $16.00
10/13/2023Stifel NicolausInitiated CoverageHold$18.00
10/12/2023Piper SandlerLower Target$26.00 ➝ $20.00
9/27/2023Morgan StanleyReiterated RatingOverweight$27.00
9/15/2023GuggenheimLower TargetBuy ➝ Buy$32.00 ➝ $30.00
8/16/2023GuggenheimLower TargetBuy ➝ Buy$34.00 ➝ $32.00
8/4/2023CitigroupLower Target$39.00 ➝ $30.00
8/4/2023Morgan StanleyReiterated RatingOverweight ➝ Overweight$32.00
6/22/2023Piper SandlerLower Target$42.00 ➝ $36.00
5/8/2023CitigroupBoost Target$32.00 ➝ $39.00
5/5/2023Lake Street CapitalBoost Target$38.00 ➝ $41.00
5/5/2023Piper SandlerBoost Target$36.00 ➝ $42.00
4/10/2023Lake Street CapitalInitiated CoverageBuy$38.00
4/5/2023Robert W. BairdDowngradeOutperform ➝ Neutral$34.00
3/13/2023GuggenheimBoost TargetBuy$29.00 ➝ $31.00
3/6/2023CitigroupBoost TargetBuy$31.00 ➝ $32.00
3/3/2023Morgan StanleyBoost TargetOverweight$28.00 ➝ $30.00
3/3/2023Raymond JamesBoost TargetStrong-Buy$30.00 ➝ $32.00
3/3/2023Robert W. BairdBoost Target$32.00 ➝ $34.00
2/15/2023CitigroupBoost TargetBuy$29.00 ➝ $31.00
1/31/2023Morgan StanleyBoost TargetOverweight$26.00 ➝ $28.00
1/13/2023B. RileyBoost TargetBuy$30.00 ➝ $32.00
1/10/2023Robert W. BairdBoost TargetOutperform$30.00 ➝ $32.00
12/6/2022CitigroupInitiated CoverageBuy$29.00
11/18/2022Robert W. BairdBoost Target$26.00 ➝ $30.00
11/16/2022GuggenheimBoost Target$26.00
11/11/2022Morgan StanleyBoost TargetOverweight$25.00 ➝ $26.00
11/11/2022Raymond JamesBoost TargetStrong-Buy$29.00 ➝ $30.00
11/11/2022B. RileyBoost TargetBuy$29.00 ➝ $30.00
11/11/2022Piper SandlerBoost TargetOverweight$34.00 ➝ $36.00
9/15/2022B. RileyInitiated CoverageBuy$29.00
8/12/2022Raymond JamesBoost TargetStrong-Buy$27.00 ➝ $29.00
3/14/2022Evercore ISIInitiated CoverageOutperform$34.00
3/14/2022Robert W. BairdBoost Target$26.00 ➝ $28.00
3/7/2022Robert W. BairdBoost Target$26.00 ➝ $28.00
3/4/2022Raymond JamesLower TargetStrong-Buy$28.00 ➝ $27.00
11/16/2021Roth CapitalInitiated CoverageBuy$29.00
11/12/2021Raymond JamesBoost TargetStrong-Buy$14.00 ➝ $28.00
11/12/2021Morgan StanleyBoost TargetOverweight$21.00 ➝ $23.00
11/12/2021Robert W. BairdBoost TargetOutperform$16.00 ➝ $26.00
11/12/2021Piper SandlerBoost TargetOverweight$20.00 ➝ $32.00
10/15/2021Robert W. BairdReiterated RatingBuy$16.00
9/28/2021Jefferies Financial GroupInitiated CoverageBuy$18.00
9/22/2021Raymond JamesUpgradeMarket Perform ➝ Strong-Buy$14.00
8/17/2021Bank of AmericaInitiated CoverageBuy$18.00
8/17/2021Raymond JamesInitiated CoverageMarket Perform
8/17/2021CitigroupInitiated CoverageBuy$14.50
8/17/2021Jefferies Financial GroupInitiated CoverageBuy$18.00
8/17/2021Robert W. BairdInitiated CoverageOutperform$16.00
8/17/2021Morgan StanleyInitiated CoverageOverweight$17.00
8/17/2021Piper SandlerInitiated CoverageOverweight$20.00
8/17/2021GuggenheimInitiated CoverageBuy
(Data available from 10/23/2019 forward)

News Sentiment Rating

0.92 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 17 very positive mentions
  • 55 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
Mentions as of
3/27/2024
  • 11 very positive mentions
  • 33 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
4/26/2024
  • 11 very positive mentions
  • 17 positive mentions
  • 2 negative mentions
  • 1 very negative mentions
Mentions as of
5/26/2024
  • 9 very positive mentions
  • 7 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
6/25/2024
  • 6 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
7/25/2024
  • 13 very positive mentions
  • 11 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
8/24/2024
  • 7 very positive mentions
  • 8 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
9/23/2024
  • 11 very positive mentions
  • 7 positive mentions
  • 0 negative mentions
  • 1 very negative mentions
Mentions as of
10/23/2024

Current Sentiment

  • 11 very positive mentions
  • 7 positive mentions
  • 0 negative mentions
  • 1 very negative mentions

Recent Stories by Sentiment

Very Negative

Negative

  • No negative mentions tracked during this time.

Positive

Very Positive

Xponential Fitness logo
Xponential Fitness, Inc., through its subsidiaries, operates as a boutique fitness franchisor in North America. It offers pilates, indoor cycling, barre, stretching, rowing, dancing, boxing, running, functional training, and yoga services under the Club Pilates, Pure Barre, CycleBar, StretchLab, Row House, YogaSix, Rumble, AKT, Stride, and BFT brands. Xponential Fitness, Inc. was founded in 2017 and is headquartered in Irvine, California.
Read More

Today's Range

Now: $13.18
Low: $12.48
High: $13.26

50 Day Range

MA: $12.96
Low: $11.87
High: $14.50

52 Week Range

Now: $13.18
Low: $7.40
High: $18.95

Volume

269,003 shs

Average Volume

679,632 shs

Market Capitalization

$633.59 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.18

Frequently Asked Questions

What sell-side analysts currently cover shares of Xponential Fitness?

The following equities research analysts have issued research reports on Xponential Fitness in the last year: B. Riley, Bank of America Co., Citigroup Inc., Guggenheim, Piper Sandler, Raymond James, Robert W. Baird, Roth Capital, Roth Mkm, and Stifel Nicolaus.
View the latest analyst ratings for XPOF.

What is the current price target for Xponential Fitness?

9 Wall Street analysts have set twelve-month price targets for Xponential Fitness in the last year. Their average twelve-month price target is $17.28, suggesting a possible upside of 31.1%. Citigroup Inc. has the highest price target set, predicting XPOF will reach $21.00 in the next twelve months. B. Riley has the lowest price target set, forecasting a price of $12.00 for Xponential Fitness in the next year.
View the latest price targets for XPOF.

What is the current consensus analyst rating for Xponential Fitness?

Xponential Fitness currently has 4 hold ratings, 4 buy ratings and 2 strong buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Moderate Buy."
View the latest ratings for XPOF.

What other companies compete with Xponential Fitness?

Other companies that are similar to Xponential Fitness include iQIYI, Rush Street Interactive, Super Group, Cedar Fair and Atlanta Braves. Learn More about companies similar to Xponential Fitness.

How do I contact Xponential Fitness' investor relations team?

The company's listed phone number is 949-346-3000 and its investor relations email address is [email protected]. The official website for Xponential Fitness is www.xponential.com. Learn More about contacing Xponential Fitness investor relations.